Applied Radiology
LOGIN TO YOUR MYAR CE ACCOUNT
Forgot Your Password? Register Submit
Applied Radiation Oncology
Applied Radiation Oncology (ARO) is pleased to offer you a selection of free SA-CME accredited courses to choose from, as part of your free subscription to ARO.
SA-CME
Accreditation/Designation Statement
These credits qualify as SA-CME credits based on the criteria of the American Board of Radiology.
The Institute for Advanced Medical Education (IAME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Institute for Advanced Medical Education (IAME) designates these Journal-based activities for a maximum of 1 AMA PRA Category 1 Credit™ each. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Managing Anxiety and Minimizing Sedation Requirements in the Pediatric Radiation Oncology Population
Nathaniel Goldman, BA*; Matthew Gallitto, MD*; Cheng-Chia Wu, MD, PhD
Estimated time for completion: 1 hour   •   Date of release and review: March 1, 2021   •   Expiration Date: February 28, 2023
This review article provides a thorough outline of various modalities to help guide implementation of strategies to reduce anxiety in treatment facilities. Categories include interventions before treatment (psychoeducational interventions, play therapy) and during treatment (specialized staff, environmental modifications, distraction, reward/incentive systems).
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Applications of Artificial Intelligence in Head and Neck Radiation Therapy
Adam C. Riegel, PhD, DABR
Estimated time for completion: 1 hour   •   Date of release and review: March 1, 2021   •   Expiration Date: February 28, 2023
The purpose of this article is to review recent advancements in artificial intelligence (AI) as they specifically pertain to head-and-neck radiation oncology. The main focus will be applications and clinical impact of these techniques. Specifically, this article addresses autosegmentation of organs at risk (OARs), autosegmentation of target volumes, treatment planning and predictive dose calculation, image-guided adaptive radiation therapy, prognosis and outcome prediction, and quality assurance.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Disparities in Colorectal Cancer Outcomes Among Young Adults and African Americans in the United States
Maya C. Graves, MS; Janna Z. Andrews, MD
Estimated time for completion: 1 hour   •   Date of release and review: December 1, 2020   •   Expiration Date: November 30, 2022
This article reviews current literature continuing to highlight persistent disparities in the diagnosis, treatment and survival outcomes in colorectal cancer in young adults and Black individuals. Topics discussed include screening recommendations, age disparity, racial disparity, and differences in outcomes between Black and White patients in the growing cohort of young adult patients.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Disparities In Lung Cancer for Black Patients In The US: An Overview of Contributing Factors and Potential Strategies for Radiation Oncologists To Bridge the Gap
Victor E. Chen, MD; Joseph F. Lombardo, DO, PharmD; Serguei A. Castaneda, MD; Karen M. Winkfield, MD, PhD; Scot A. Fisher, DO; Eric L. Gressen, MD; Shari B. Rudoler, MD; Weisi Yan, MD, PhD; Shefali R. Gajjar, MD
Estimated time for completion: 1 hour   •   Date of release and review: December 1, 2020   •   Expiration Date: November 30, 2022
This review article describes key factors that contribute to lung cancer disparities for Black patients and discusses strategies and future directions for radiation oncologists to bridge the gap. Topics discussed are contributing factors for disparities in lung cancer incidence, disparities in lung cancer prevention, disparities in lung cancer treatment and outcomes, and potential strategies to overcome barriers.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Radiotherapeutic Management of Oligometastatic Disease in Low- and Middle-Income Countries: The Current State of Affairs and Perspectives on Future Implementation
Angela Y. Jia, MD, PhD; Matthew P. Deek, MD; and Ryan M. Phillips, MD, PhD
Estimated time for completion: 1 hour   •   Date of release and review: September 1, 2020   •   Expiration Date: June 30, 2022
This review provides a perspective regarding barriers to expansion of radiation treatments in low- and middle-income countries (LMICs). The authors review the benefit of expanding radiation treatment to patients with oligometastatic disease based on several recent clinical trials including SABR-COMET, ORIOLE, and others. The authors also discuss limitations and barriers to receiving radiation treatment in less developed countries including the sparsity of treatment machines, personnel expertise, and distribution of resources in urban vs rural environments. They further discuss technological advances that may help to develop and increase access to radiation therapy in LMICs.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Management of Oligometastatic Prostate Cancer
James R. Broughman, MD; Christopher W. Fleming, MD; Omar Y. Mian, MD, PhD; Kevin L. Stephans, MD; Rahul D. Tendulkar, MD
Estimated time for completion: 1 hour   •   Date of release and review: September 1, 2020   •   Expiration Date: June 30, 2022
Recent data suggests that aggressive treatment of the primary tumor or metastasis-directed therapy may confer a survival advantage in carefully selected patients with metastatic prostate cancer. This review outlines treatment approaches for these patients, while highlighting existing literature, ongoing trials, and important areas for future study.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Transcriptional Mechanisms of Radioresistance and Therapeutic Implications
Daniel Y. Kim, BS*; Jimmy A. Guo, BA*; Daniel Zhao, BA; Errol J. Philip, PhD; Yun R. Li, MD, PhD
Estimated time for completion: 1 hour   •   Date of release and review: March 1, 2020   •   Expiration Date: February 28, 2022
While numerous mechanisms impact sensitivity to radiation, the authors examine the transcriptional alterations and gene expression programs that allow neoplastic cells to withstand radiation. They review the recurring mechanisms co-opted by cancer cells in radiation resistance: upregulation of DNA repair, suppression of apoptotic programs, hypoxia, immune evasion and exhaustion, cellular plasticity, as well as aberrant intracellular signaling. They also explore the therapeutic implications of these preclinical findings.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Management of Head and Neck Cancer Patients During the Epidemic of COVID-19 in Wuhan
Qiuji Wu, MD, PhD; Xiting Yang, MS; Fengyang Wu, MS; Yahua Zhong, MD, PhD
Estimated time for completion: 1 hour   •   Date of release and review: June 1, 2020   •   Expiration Date: May 31, 2022
The rapid spread of the new coronavirus disease (COVID-19) identified toward the end of 2019 significantly impacted everyone in China, and all over the world. Head and neck (HN) cancers are a common malignant tumor type in China, with chemoradiation the standard of care for locally advanced disease. However, the COVID-19 epidemic interrupted the routine diagnosis and treatment of all cancers, including HN cancers, which can progress quickly if treatment is significantly delayed. Cancer patient care at the epicenter of COVID-19 was particularly challenged. Based on the management experience of patients with HN cancer during the outbreak of COVID-19 at a cancer institute in Wuhan, the authors summarize management strategies of patients with HN cancer to provide reference for health care providers facing similar challenges.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Leading a Radiation Medicine Department from the Epicenter of the COVID-19 Pandemic in the United States
Daniel Koffler, MD; Sewit Teckie, MD; Louis Potters, MD, FACR, FASTRO, FABS
Estimated time for completion: 1 hour   •   Date of release and review: June 1, 2020   •   Expiration Date: May 31, 2022
Cardiotoxicity can be an unfortunate side effect from cancer therapies including chemotherapy, hormonal therapy, and radiation therapy (RT). Sub-acute cardiotoxicity can occur during systemic therapies but is often considered a late effect from RT. This manuscript reviews the current literature regarding the clinical impact of radiation-induced cardiotoxicity in the setting of breast cancers and thoracic malignancies including lung cancer, esophageal cancer and mediastinal lymphomas.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Cardiotoxicity and Radiation Therapy: A Review Of Clinical Impact In Breast and Thoracic Malignancies
Elizabeth M. Nichols, MD; Arezoo Modiri, PhD; Pranshu Mohindra, MD, MBBS
Estimated time for completion: 1 hour   •   Date of release and review: March 1, 2020   •   Expiration Date: February 28, 2022
Cardiotoxicity can be an unfortunate side effect from cancer therapies including chemotherapy, hormonal therapy, and radiation therapy (RT). Sub-acute cardiotoxicity can occur during systemic therapies but is often considered a late effect from RT. This manuscript reviews the current literature regarding the clinical impact of radiation-induced cardiotoxicity in the setting of breast cancers and thoracic malignancies including lung cancer, esophageal cancer and mediastinal lymphomas.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Noninvasive Cardiac Radioablation at Washington University: Past, Present and Future Directions for the Treatment of Ventricular Tachycardia
Pamela Samson, MD, MPHS; Geoff Hugo, PhD; Kaitlin Moore, BSN; Nels Knutson, PhD; Philip Cuculich, MD; Clifford Robinson, MD
Estimated time for completion: 1 hour   •   Date of release and review: March 1, 2020   •   Expiration Date: February 28, 2022
Noninvasive cardiac radioablation using stereotactic body radiation therapy (SBRT) techniques has emerged as a potential salvage treatment option for patients with ventricular tachycardia who have either failed procedural or medical management, or have contraindications to receive those therapies again. The recently published phase I/II Electrophysiology-Guided (EP) Noninvasive Cardiac Radioablation for Ventricular Tachycardia trial (ENCORE-VT, NCT02919618) demonstrated early safety and efficacy of this novel use of SBRT. This article reviews the lessons learned from ENCORE-VT, current use and workflow for treatment refractory ventricular tachycardia patients, and future directions for this emergent treatment modality.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
An Emergent Role For Radiomic Decision Support In Lung Cancer
Gleb A. Kuzmin, PhD;* Mishka Gidwani, BS;* Tianjun Ma, PhD;* Tingliang Zhuang, PhD; Mohamed E. Abazeed, MD, PhD
Estimated time for completion: 1 hour   •   Date of release and review: December 1, 2019   •   Expiration Date: November 30, 2021
This review article discusses recent developments in radiomics—a computational image evaluation technique that integrates medical images, clinical data, and machine learning—its applications to lung cancer treatments, and the challenges associated with radiomics as a tool for precision diagnostics and theranostics.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Genomics and Radiomics: Tools To See The Unseen To Personalize Radiation Therapy
G. Daniel Grass, MD, PhD; Matthew N. Mills, MD; Jacob G. Scott, MD, DPhil; Steven A. Eschrich, PhD; Javier Torres-Roca, MD
Estimated time for completion: 1 hour   •   Date of release and review: December 1, 2019   •   Expiration Date: November 30, 2021
Genomics and radiomics provide an opportunity to increase the precision of radiation delivery in selection of dose and spatial delivery. Further understanding of host and tumor differences with interrogative approaches may provide opportunity to precisely deliver radiotherapy beyond spatial and anatomic features to one guided by intrinsic tumor biology. This article addresses how tumor genomic blueprints can be exploited for radiation therapy; radiomics as a noninvasive means to assessing tumor biology; clinical applications regarding treatment response, treatment planning, and toxicity; and radiogenomics utility.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Chemoradiation Treatment of Glioblastoma Multiforme: Treatment Guidelines and Considerations
Krissia Margarita Rivera Perla, ScB; Ollin Gomez Venegas, BA; Steven A. Toms, MD, MPH
Estimated time for completion: 1 hour   •   Date of release and review: September 1, 2019   •   Expiration Date: August 31, 2021
Authors review the North American and European guidelines for chemoradiation of GBM created as a result of the new 2016 WHO classification system, focusing specifically on age, performance status, molecular markers, and disease recurrence. They also discuss factors such as socioeconomic and insurance status that impact radiation treatment compliance and GBM outcomes.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Multimodality Management of Colorectal Liver Oligometastases
Shauna R. Campbell, DO; Ehsan H. Balagamwala, MD; Neil M. Woody, MD, MS; Kevin L. Stephans, MD
Estimated time for completion: 1 hour   •   Date of release and review: September 1, 2019   •   Expiration Date: August 31, 2021
Authors examine modern treatment approaches to limited liver metastases from colorectal cancer, discussing the intent and sequencing of treatment, chemotherapy, surgical resection, radiofrequency ablation/cryoablation, chemoembolization, radioembolization, external-beam radiation therapy, stereotactic body radiation therapy (SBRT), and proton therapy and the indication for each modality. The review also describes circumstances in which SBRT is preferred over other liver-directed therapies.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Proton Therapy for Colorectal Cancer
Saira E. Alex, BS; Eric D. Brooks, MD; Emma B. Holliday, MD
Estimated time for completion: 1 hour   •   Date of release and review: September 1, 2019   •   Expiration Date: August 31, 2021
Based on current standards, colon cancer is treated with surgical resection and chemotherapy, and rectal cancer is treated with preoperative radiotherapy. This review of the literature suggests the potential for improved local control and reduced toxicity when treating colorectal cancer with proton therapy compared to the current treatment paradigms. Additionally, surgery and ablative techniques have traditionally been used to treat metastatic colorectal cancer. This review discusses how proton therapy could offer an alternative approach to reduce toxicity and act in lieu of surgery in the metastatic setting.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
The Safety and Efficacy of Combined Immunotherapy and Radiation Therapy
Shwetha Manjunath, MD; Jacob E. Shabason, MD, MTR
Estimated time for completion: 1 hour   •   Date of release and review: March 1, 2019   •   Expiration Date: February 29, 2020
To date, there is little consensus on how to best combine radiation and immune checkpoint blockade (ICB) to maximize therapeutic gains while minimizing the potential for serious overlapping toxicities. This review summarizes relevant clinical data related to both safety and efficacy of the combination of ICB and radiation.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)